Trials / Unknown
UnknownNCT04214730
Study of NK Combined With Chemotherapy for Advanced Solid Tumor
Study of Natural Killer Cell Combined With Chemotherapy for Advanced Solid Tumor
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Yantai Yuhuangding Hospital · Academic / Other
- Sex
- All
- Age
- 10 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Combinations Natural Killer Cell (NK) With chemotherapy treatment may enhance the immune response and stop cancer cells from growing.
Detailed description
Patients in group A will receive 4 cycles of NK treatments within 8 months. Patients in group B will have no immunotherapy. Chemotherapy are available in both groups.The investigators want to evaluate the efficacy of combination of NK with chemotherapy in patients with treatment-refractory solid tumors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | NK combined with Chemotherapy | Patients will receive 4 cycles of NK treatments combined with Chemotherapy within 8 months |
| DRUG | Chemotherapy | Patients will only receive Chemotherapy. |
Timeline
- Start date
- 2019-12-31
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2020-01-02
- Last updated
- 2023-03-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04214730. Inclusion in this directory is not an endorsement.